Shopping Cart
Remove All
Your shopping cart is currently empty
Hexyl gallate (Gallic acid hexyl ester), an alkyl ester derivative of gallic acid, exhibits potent antimalarial activity against Plasmodium falciparum (IC50: 0.11 mM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $31 | In Stock | In Stock | |
| 50 mg | $44 | In Stock | In Stock | |
| 100 mg | $64 | In Stock | In Stock | |
| 200 mg | $109 | In Stock | In Stock | |
| 500 mg | $183 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $39 | In Stock | In Stock |
| Description | Hexyl gallate (Gallic acid hexyl ester), an alkyl ester derivative of gallic acid, exhibits potent antimalarial activity against Plasmodium falciparum (IC50: 0.11 mM). |
| Targets&IC50 | Antimalarial:0.11 mM |
| In vitro | Hexyl gallates (Hexyl 3,4,5-trihydroxybenzoate) selectively inhibit RhlR-dependent production of rhamnolipid and pyocyanin, impacting only Rhl-regulated pathways while preserving elastase production and biofilm formation controlled by the Las system. These compounds show pigment inhibition at concentrations of 10-30 μM and exhibit notable antibacterial properties. Hexyl gallates also suppress N-butanoyl homoserine lactone (BHL) production at 100 and 300 μM, without affecting N-(3-oxododecanoyl)-l-homoserine lactone (OdDHL) and 2-heptyl-3-hydroxy-4(1H) quinolone (PQS) synthesis. As a promising antimicrobial alternative to copper compounds, Hexyl gallates effectively inhibit Xanthomonas citri growth at 30-50 μg/ml by targeting the bacterium's membrane, demonstrating a dose-responsive behavior. |
| Synonyms | Hexyl 3,4,5-trihydroxybenzoate, Gallic acid hexyl ester |
| Molecular Weight | 254.28 |
| Formula | C13H18O5 |
| Cas No. | 1087-26-9 |
| Smiles | CCCCCCOC(=O)c1cc(O)c(O)c(O)c1 |
| Relative Density. | 1.239 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (196.63 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.87 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.